Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$13.58 USD
-0.42 (-3.00%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $13.59 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
04/25/2024
Time: BMO |
3/2024 | $-1.63 | -7.77% |
Earnings Summary
For their last quarter, Sage Therapeutics (SAGE) reported earnings of -$1.80 per share, missing the Zacks Consensus Estimate of -$1.63 per share. This reflects a negative earnings surprise of 10.43%. Look out for SAGE's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.62 per share, reflecting a year-over-year increase of 33.74%.
Earnings History
Price & Consensus
Zacks News for SAGE
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
SAGE: What are Zacks experts saying now?
Zacks Private Portfolio Services